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Abstract
Background
As the application of carbon nanotubes (CNT) in consumer products continues to rise, stud-
ies have expanded to determine the associated risks of exposure on human and environ-
mental health. In particular, several lines of evidence indicate that exposure to multi-walled
carbon nanotubes (MWCNT) could pose a carcinogenic risk similar to asbestos fibers. How-
ever, to date the potential markers of MWCNT exposure are not yet explored in humans.
Methods
In the present study, global mRNA and ncRNA expression profiles in the blood of exposed
workers, having direct contact with MWCNT aerosol for at least 6 months (n = 8), were com-
pared with expression profiles of non-exposed (n = 7) workers (e.g., professional and/or
technical staff) from the same manufacturing facility.
Results
Significant changes in the ncRNA and mRNA expression profiles were observed between
exposed and non-exposed worker groups. An integrative analysis of ncRNA-mRNA correla-
tions was performed to identify target genes, functional relationships, and regulatory net-
works in MWCNT-exposed workers. The coordinated changes in ncRNA and mRNA
expression profiles revealed a set of miRNAs and their target genes with roles in cell cycle
regulation/progression/control, apoptosis and proliferation. Further, the identified pathways
and signaling networks also revealed MWCNT potential to trigger pulmonary and cardiovas-
cular effects as well as carcinogenic outcomes in humans, similar to those previously
described in rodents exposed to MWCNTs.
PLOS ONE | DOI:10.1371/journal.pone.0150628 March 1, 2016 1 / 32
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Conclusion
This study is the first to investigate aberrant changes in mRNA and ncRNA expression pro-
files in the blood of humans exposed to MWCNT. The significant changes in several miR-
NAs and mRNAs expression as well as their regulatory networks are important for getting
molecular insights into the MWCNT-induced toxicity and pathogenesis in humans. Further
large-scale prospective studies are necessary to validate the potential applicability of such
changes in mRNAs and miRNAs as prognostic markers of MWCNT exposures in humans.
Introduction
Nanotechnology presents new opportunities to create superior materials with novel applica-
tions. At present, nanomaterial (NM) containing products are available in U.S. and worldwide
markets including coatings, computers, clothing, cosmetics, sports equipment and medical
devices. NMs have experienced rapid and substantial industrial growth globally. In fact, this
manufacturing growth is accompanied by questions regarding potential risks to human health.
Meanwhile, epidemiological studies documented the effect of air pollution on pulmonary, and
cardiovascular morbidity, and mortality. Toxicological literature describes the translocation of
carbonaceous NM across the alveolar-capillary barrier into the circulatory and lymphatic sys-
tems, providing access to most organs in the body [1–5].
Multiwalled carbon nanotubes (MWCNTs) are allotropes of carbon that are formally
viewed as a tubular structure rolled up from a graphene sheet. The cylindrical nature of
MWCNT, exceptional mechanical strength and intrinsic physico-chemical properties are in
use for a number applications in electronics, optics, materials science, polymer chemistry and
nanocomposites[6, 7]. MWCNTs have diameters in the range of 2−10 nm for the innermost
tubular layer and an additional thickness of*0.7 nm for every extra layer. Different chiral vec-
tors, which describe how the graphene sheets are rolled up, result in MWCNTs with different
electronic structure. They are either semiconducting or metallic [8]. Because of the high aspect
ratio and good conductivity, MWCNTs are especially promising as conductive fillers for mak-
ing polymeric composites with high-strength and electric-shielding properties [9–11].
Enlarged volume of MWCNTs manufacturing has raised concerns over potential risks of
adverse health effects in humans since there is the likelihood of rising with time. Due to
unique physical and chemical features, MWCNTs may have quite unusual pulmonary
responses [12–14]. Several studies have focused on respiratory toxicity, particle retention and
low pulmonary clearance observed in the lungs of exposed animals resembling malaise effects
of asbestos [2, 12, 15]. The high aspect ratio, size distribution and biopersistence of MWCNTs
is likely associated with pulmonary inflammation, damage, fibrogenicity along with their abil-
ity to potentiate tumorigenesis in rodents poses a major safety concern. Recently, the Interna-
tional Agency for Research on Cancer (IARC) has classified MWCNT-7 (Mitsui Ltd., Japan)
to a Category 2B: possibly carcinogenic to humans [16]. Potential human exposures to NMs
or their mixtures include workers exposed during the production and use of NM, general pop-
ulation exposure from releases into the environment and human exposure during the use of
commercially available products. However, to date the potential markers of MWCNT expo-
sure and their plausible adverse health outcomes are not yet explored in humans.
The non-coding RNAs (ncRNA), especially long non-coding RNAs (lncRNA) and micro
RNAs (miRNA) have emerged as crucial regulators of various biological processes by interfer-
ing with gene expression. The miRNAs, a class of small single-stranded ncRNAs (22 nt),
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negatively regulate gene expression through partial base-pairing with target genes or coding
messenger RNAs (mRNA). In contrast, lncRNAs, a set of diverse ncRNAs, have been shown to
regulate gene expression through various mechanisms, including complementary binding to
mRNAs in the form of cis-antisense lncRNAs, modulating transcription factors[17–21].
Despite attracting a great deal of interest in several human disease conditions including cancer
[22–24], systematic and integrative analyses of different types of RNA molecules have been
very rare in the field of nanotoxicology. Thus an integrated analysis involving both coding-
noncoding RNAmolecules is critical for determining and understanding the regulatory net-
works and molecular mechanisms underlying MWCNT induced biological responses and tox-
icity in humans. In this paper, we determined and evaluated changes in global non-coding
lncRNAs/miRNAs and coding mRNA expression profiles, through genome-wide approaches,
in the whole blood samples of workers exposed to the MWCNT aerosols from manufacturing
facilities vs non-exposed individuals. The changes in the miRNA/mRNA expression profiles
were correlated with known adverse cardiopulmonary outcomes associated with MWCNT
exposures in rodents. Functional and pathway enrichment analysis was performed to identify
genes and pathways that may contribute to MWCNT-induced outcomes in humans. Further-
more, we performed an integrated analysis of ncRNA-mRNA targets based on their interac-
tions and positional information to suggest and generate a regulatory network of interactions
between lncRNAs, miRNAs and mRNAs in MWCNT-exposed workers. The changes in cod-
ing-noncoding RNAs identified in the present study may have a promising potential as relevant
blood markers for monitoring MWCNT exposure in humans.
Materials and Methods
Exposure Assessment
As part of this study, workplace/occupational exposure assessments were conducted at the
Nanotech Center Ltd. (Tambov, Russia) MWCNT manufacturing facility. Air sampling was
performed during the main operations (harvesting, disintegration, packaging, laboratory han-
dling) throughout the production process. Samples were collected on ultraclean, 25-mm
quartz-fiber filters (Pallflex Tissuquartz™, 2500 QAT-UP) using PU-4E pumps (Khimko JSC,
Moscow, Russia) operating at 2–4 L min-1. A total of 270 L of air was sampled. After sample
collection, the quartz filters were analyzed for elemental carbon (EC) according to NIOSH
Method 5040 [3], recommended by NIOSH for assessing airborne exposure to CNTs and car-
bon nanofibers (CNFs)[25]. The analysis is based on a thermal-optical technique for organic
and elemental carbon (OC and EC), with EC being a measure of the CNT/CNF mass. Bulk
CNT samples also were analyzed to obtain their thermal profiles. As discussed previously [25,
26], CNT (and CNF) aerosols contain micrometer-size agglomerates. The automated OC-EC
split that is normally assigned in the 5040 analysis is helpful to OC-EC speciation for complex
carbonaceous aerosols, but the optical technique used for speciation was intended for fine/
ultrafine aerosols. Because sample transmittance (absorbance) has a particle-size dependence,
with larger particles having less light attenuation, the auto-split may underestimate CNT mass
due to the relatively large particle size. This problem can be avoided through manual assign-
ment of the split, based on the results for bulk materials (microgram amounts) and background
samples. In this study, environmental background EC was negligible and posed no interference
in the CNT measurement. In addition, the CNT materials contained little OC, if any, and they
were fully oxidized during the oxidative mode (920°C maximum) of the analysis. As such,
quantification of the CNT filter content was straightforward.
Background samples for EC were collected in the same manner at each facility to account
for any external sources of EC, not related to MWCNT manufacturing and handling. To
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confirm the presence of MWCNTs, air samples were also collected on 37-mm diameter mixed
cellulose ester (MCE) filters (0.8 μm pore size; SKC, Inc., USA) for analysis by transmission
electron microscopy (TEM). The TEM samples were analyzed on a JEOL2100F TEM (JEOL
USA, Inc., Peabody, MA, USA) using a modified NMAM 7402 [27]. These modifications con-
sist mostly of eliminating all steps necessary to positively identify asbestos [26]. The modifica-
tions mainly relate to counting CNT/CNF particles, which, unlike asbestos fibers, occur mainly
as micrometer-sized agglomerates. Three 3 mm, copper TEM grids from each sample were
examined at low magnification to determine loading and sample preparation quality. Elemen-
tal spectra were also obtained using energy dispersive x-ray analysis (EDXA).
Study subjects and data collection
The physico-chemical properties of MWCNTs manufactured and/or used in the Nanotech
Center Ltd. facility are listed in S1 Table. A total of 8 workers exposed to MWCNTs and 7 non-
exposed controls from the same facility were recruited to take part in this study. The classifica-
tion of exposed workers and non-exposed controls was based on work duties and confirmed by
the presence and absence, respectively, of MWCNTs in personal breathing zones (PBZ) sam-
ples (S2 Table). The non-exposed controls were selected from workers at the same sites as the
exposed workers, but who did not handle MWCNTs. The Institutional Review Board of Kazan
State Medical University, Kazan, Russia, approved this study under the protocol№14 dated
December 26, 2011. Informed consent was obtained from each of the subjects after a detailed
explanation of the nature and possible consequences of the study by the interviewer on the day
of the personal interview. After a written informed consent was obtained from individual par-
ticipants, the subjects were interviewed in person using a structured questionnaire and health
examinations. Demographic and health data included age, gender, pernicious habits, work
experience, and history of disease. Exposure group inclusion criteria were as follows: age 18–60
y; no less than 6 months work experience with MWCNT exposure (based on hygienic work-
place investigation); no acute or chronic respiratory, cardiovascular or connective tissue dis-
eases, no recent traumas, arterial pressure no more than 140/90 mmHg.; no general medical
contraindications to the blood collection. In order to eliminate the potential effects of other
confounding factors such as sex and smoking, in addition to MWCNTs, males who are non-
smokers were considered for performing detailed whole blood gene expression profiling stud-
ies. While the non-exposed group (n = 7) was comprised of individuals in the age range 20–30
yrs old, the MWCNT exposed group (n = 8) involved workers with ages 23–60 yrswho spent
an average of ~ 6–24 months working in the facility.
Blood sample collection and storage
Peripheral whole blood (~2–2.5 mL) from venipuncture was dispensed into the PAXgene™
Blood RNA Tubes (Qiagen). The sample was gently inverted and frozen at -80°C within two
hours of collection.
Total RNA isolation and quality assessments
RNA was extracted from whole blood using the PAXgene™ Blood RNA System Kit following
manufacturer's guidelines. Briefly, the samples were removed from -80°C and incubated at
room temperature for 2 hours to ensure complete lysis. Following lysis the tubes were centri-
fuged for 10 min at 5,000 × g, the supernatant decanted and 500 μL of RNase-free water added
to the pellet. After washing with 500 μl RNase-free water, the pellet was dissolved in 350 μl
resuspension buffer and incubated with 300 μl binding buffer and 40 μl proteinase K for 10
min at 55°C in a shaker-incubator. The lysate was transferred into a PAXgene shredder spin
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column and centrifuged (at 18,000 g for 3 min). The flow-through fraction was mixed with
350 μl ethanol and transferred to a PAXgene RNA spin column. After washing the column
with washing buffer 1, samples were incubated with 10 μl of DNase I for 15 min. PAXgene
RNA spin columns were washed with washing buffer and RNA eluted with 40 μl elution buffer.
The RNA yield was estimated by measuring absorbance at 260 nm in a NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). RNA purity was calcu-
lated from the ratio of absorbance at 260 nm and 280 nm, and RNA integrity was assessed by
standard denaturing agarose gel electrophoresis.
LncRNA &mRNA labeling, array hybridization and data analysis
Human LncRNA microarray V3.0, designed by ArrayStar Inc, was employed to perform global
profiling of human LncRNAs (~30,586) and protein-coding (~26,109) transcripts. Sample
labeling and array hybridization were performed according to the Agilent One-Color Microar-
ray-Based Gene Expression Analysis protocol (Agilent Technology) with minor modifications.
Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY™ Eukary-
otic mRNA Isolation Kit, Epicentre). Then, each sample was amplified and transcribed into
fluorescent cRNA along the entire length of the transcripts without 3’ bias utilizing a random
priming method. The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen). The concen-
tration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA) were measured by
NanoDrop ND-1000. 1 μg of each labeled cRNA was fragmented by adding 5 μl 10 × Blocking
Agent and 1 μl of 25 × Fragmentation Buffer, then heated the mixture at 60°C for 30 min,
finally 25 μl 2 × GE Hybridization buffer was added to dilute the labeled cRNA. 50 μl of hybrid-
ization solution was dispensed into the gasket slide and assembled to the LncRNA expression
microarray slide. The slides were incubated for 17 hours at 65°C in an Agilent Hybridization
Oven. The hybridized arrays were washed, fixed and scanned using the Agilent DNAMicroar-
ray Scanner (part number G2505C).
Agilent Feature Extraction software (version 11.0.1.1) was used to analyze acquired array
images. Quantile normalization and subsequent data processing were performed with using
the GeneSpring GX v11.5.1 software package (Agilent Technologies). The LncRNAs and
mRNAs showing expression changes of at least 1.5-fold in MWCNT-exposed group compared
to non-exposed controls and having p-values of less than or equal to 0.05 (p 0.05, t-test)
were considered significantly differentially expressed and were considered for further analysis.
Hierarchical Clustering was performed using the Agilent GeneSpring GX software (version
11.5.1). All lncRNA and mRNA expression data were deposited to NCBI's Gene Expression
Omnibus and is accessible via accession number (ID: GSE73830). To allow for the identifica-
tion and determination of MWCNT related exposure markers, the samples corresponding to
the MWCNT exposure group were further grouped into two categories: (i) overall exposure
group—consisting all MWCNT exposed workers and (ii) high exposure group—workers
exposed to MWCNT lung burdens of> 9μg per day (Sample IDs:- TB1, TB2 and TB14).
miRNA sequencing and expression profiling
Total RNA of each sample was used to prepare the miRNA sequencing library which includes
the following steps: 1) 3'-adapter ligation with T4 RNA ligase 2 (truncated); 2) 5'-adapter liga-
tion with T4 RNA ligase; 3) cDNA synthesis with RT primer; 4) PCR amplification; 5) extrac-
tion and purification of ~135–155 bp PCR amplified fragments (correspond to ~15–35 nt
small RNAs) from the PAGE gel. After the completed libraries were quantified with Agilent
2100 Bioanalyzer, the DNA fragments in the libraries were denatured with 0.1M NaOH to gen-
erate single-stranded DNA molecules, captured on Illumina flow cells, amplified in situ and
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finally sequenced for 36 cycles on Illumina HiSeq 2000 according to the manufacturer’s
instruction.
After sequencing images were generated, image analysis and base calling was performed
using Off-Line Basecaller software (OLB V1.8.0). Subsequently, 3’ adapter sequences were
trimmed from clean reads (reads that passed Solexa CHASTITY quality filter) and the reads
shorter than 15nt were discarded. Then the 3’-adapter-trimmed-reads (> = 15nt) were aligned
to the latest known human reference miRNA precursor set (Sanger miRBase 20) using Novoa-
lign (v2.07.11). Reads (counts< 2) were discarded when calculating the miRNA expression. In
order to characterize the isomiR variability, any sequence that matched the miRNA precursors
in the mature miRNA region ±4nt (no more than one mismatch) were accepted as mature
miRNA isomiRs, which were grouped according to the 5-prime (5p) or 3-prime (3p) arm of
the precursor hairpin.
Bioinformatics Analysis and Approaches
Identification and Prediction of LncRNA-mRNA/-miRNA interactions and miRNA-
mRNA Target pairs. The microRNA Target Filter of Ingenuity Pathway Analysis (IPA) soft-
ware was used to select only the miRNA‐mRNA target interactions that were experimentally
demonstrated or predicted with the highest level of confidence. Based on experimental data
and the information provided by the Ingenuity Knowledge Base, this tool helps users to quickly
prioritize mRNA targets using algorithms miRecords[28], TargetScan[29], and TarBase[30].
For miRNAs that were up-regulated in MWCNT-exposed workers compared to non-exposed
group, we searched for mRNA target pairs that were down-regulated, and vice versa.
The LncRNABase of StarBase v2.0 [31, 32] was used to identify and predict miRNA interac-
tions and/or targets on long non-coding RNAs. This database provides experimentally verified
and computationally predicted miRNA recognition elements (MREs) or targets on human
lncRNAs. Further the lncRNAs were classified into different subgroups and analyzed according
to their various interaction mechanisms with mRNAs. The functional relationships between
nearby coding genes and the lncRNAs with enhancer-like functions and large intervening non-
coding RNAs (lincRNAs) were screened and identified by mapping their genomic position
using GENCODE and its psuedogene, RefSeq and UCSC annotations of the human genes[33–
37], as well as previous studies by Rinn’s group[38–40].
Core Analysis using IPA. To identify and reveal biological pathways and signaling net-
works that are significantly perturbed in workers potentially exposed to MWCNTs, Ingenuity
Pathway Analysis (IPA, ver. 8.6; Redwood City, CA; www.ingenuity.com) was performed on
differentially expressed (p 0.05) mRNAs, miRNAs and their co-expressed gene targets with
consistent expression in mRNA profiles. Tab delimited text files containing gene IDs, expres-
sion data, and t-test p-values were uploaded into IPA for conducting a core analysis. A fold
change cutoff of 1.5, as well as a p-value cut-off of 0.05 was set to identify genes and/or mRNA
targets whose expression was significantly differentially regulated in each case. Score rankings
for the top molecular/cellular/biological functions, diseases, toxicology functions, and IPA-
identified gene signaling networks (GSN) were calculated using IPA-generated negative loga-
rithm p-values i.e., -log10(p-value) and associated Z- and network scores. The estimated
Fischer’s exact p-values, pathway- and network-activation scores will reflect the probability or
likelihood of genes occurring in a given pathway/biofunction/disease/network versus others is
based on pure chance or not.
Pathway enrichment analysis of mRNAs and miRNA-mRNA target pairs. Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathway enrichments on differentially expressed
genes was performed using Database for Annotation, Visualization and Integrated Discovery
Markers of CNT Exposure in Humans
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(DAVID) v6.7 software [41, 42]. DIANA-miRPath v2.0 (http://www.microrna.gr/miRPathv2),
a web-based computational tool, was used to analyze and identify molecular pathways associ-
ated with the putative targets of miRNAs [43, 44]. This program predicts miRNA targets with
high accuracy based on experimentally supported miRNA-mRNA interactions from TarBase
and also the DIANA-microT-CDS algorithm that considers the evolutional conservation of
miRNA-binding sites. An enrichment analysis, depicting the target genes of multiple miRNAs
in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways was performed. KEGG
(www.genome.jp/kegg/kegg_ja.html) is a well-known publicly accessible knowledgebase, com-
posed of manually curated 364,925 pathways that cover a wide range of metabolic, genetic,
environmental, and cellular processes and human diseases. A p-value cutoff of< 0.05 was used
for identifying significantly perturbed KEGG pathways. We also utilized the gene filtering
option of the DIANA-miRPath to filter for miRNA targets that had consistent expression in
mRNA expression profiles in the blood and a similar pathway enrichment analysis using Tar-
base, as described above, was performed using only the expressed subset of genes.
Quantitative Real Time PCR Validation of mRNAs and miRNAs. The quantification of
the six selected mRNA transcripts (CCND1, CCND3, E2F2, SOD1, TGFβ1, EGFR and MUC1)
was performed by relative quantitative real-time RT-PCR with TaqMan real-time RT-PCR
assays and 7900HT Fast Real-time PCR system (Applied Biosystems, Foster City, CA). For-
ward and reverse primers were designed using Primer Premier 5.0 software. cDNAs were gen-
erated from 1.5 μg of total RNA using SuperScript III First-Strand Synthesis SuperMix kit
(InVitrogen, Carlsbad, CA). The resulting cDNA was subjected to 40 cycle PCR amplification.
Each thermocycling reaction used 10 μl total volume containing 2 μl cDNA, 1.2 μl primers,
1.8 μl ddH2O and 5 μl PCR Master Mix. All samples corresponding to the selected mRNAs
were normalized to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH). All of the reac-
tions were run in triplicate. The mean value in each triplicate was used to calculate relative con-
centrations of each mRNA (ΔCt = Ct mean mRNAs−Ct mean GAPDH). Expression fold
changes were calculated using 2−ΔΔCt method (ΔΔCt = ΔCt MWCNT-exposed mRNAs − ΔCt unex-
posed mRNAs). The differences in the level of mRNA expression between MWCNT exposed
and unexposed subjects were analyzed using the Student’s t-test and a p-value of< 0.05 was
considered as statistically significant. Correlation between the microarray and qPCR results for
the selected genes was performed using Pearson’s correlation, and the statistical significance of
the correlations was then determined by estimating the test-statistic—t and P-value by refer-
ring to a t-distribution with n-2 degrees of freedom.
Results
TEM and EC analyses indicate presence of airborne CNT
Representative TEM images of air samples from the MWCNT facility are shown in Fig 1. TEM
analysis revealed several types of CNT particles in these samples. Most often, the particles were
entangled, agglomerated structures measuring several μm crosswise (e.g., Fig 1A–1C). How-
ever, in some cases, curved fibers or bundles of long/slender CNT structures were associated
with the agglomerates (e.g., Fig 1A). These findings are in line with previous studies that
reported the presence of both tangled and more dispersed CNT structures in air samples from
CNT manufacturing facilities [26, 45, 46].
The CNT structure counts for samples collected within the facility are reported in S2 Table.
The table reports the number of structures counted per number of grid openings (e.g., Grid 1,
mechanical grinding: 16 structures dispersed over 14 grid openings), the total number of struc-
tures per square millimeter of filter area (CNT/mm2), and the longest measured crosswise
dimension for each structure. For each structure, two additional crosswise lengths were
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measured and averaged to give a rough estimate of the minor axis, for particles with oblate
shapes, or a rough diameter for roughly spherical particles. These averages are not reported,
but in most cases, the ratio of the maximum cross-wise length to the minor axis (average) was
4:1 or less, averaging about 1.5:1.
The structures found were classified as two main types, ‘matrix’ or ‘cluster’ (S1 Fig). Matrix
structures appear as particles with dark regions and associated CNTs (S1A and S1B Fig), and
clusters are visible as mainly loose bundles of CNTs (S1C Fig). The most common structure
was the matrix type, but clusters also were present. Based on the EDXA spectra, matrix parti-
cles contained several elements, while CNT clusters contained mainly nickel and lesser
amounts of cobalt. Other types of structures (e.g., Fig 2D), without visible CNT, also were
detected in all samples in varying amounts, possibly from air pollution or other sources. None
of the clean room samples showed the presence of CNTs. However, TEM analyses of area and
PBZ samples (Fig 1A–1D) collected at the MWCNT manufacturing facilities clearly indicate
the presence of inhalable/respirable fractions of CNTs.
The EC results for personnel breathing zone samples from various processes that involve
processing/handling MWCNT are listed in S3 Table. As with the TEM analyses, the EC results
confirm the presence of airborne CNTs. Of the various processes investigated, PBZ samples
collected in the harvesting and packaging areas exhibited the highest exposure levels (S3
Table), consistent with the TEM results. In these areas, the average inhalable EC concentration
were found to be ~14.42 ± 3.8 μg/m3 (Table 1). Further, the calculated average EC concentra-
tions, indicating the MWCNT concentrations to which the study subjects are potentially
exposed on a daily basis, along with the approximate lung burdens estimated using MPPD
(v.2.1) modeling software, are listed in Table 2. Taken together, these results clearly indicate
potential MWCNT exposure at concentrations higher than the NIOSH recommended expo-
sure limit (REL) of 1 μg/m3 for an 8 h time-weighted average of EC [47] (Table 2 and S3
Table).
Fig 1. Transmission electronmicrographs of samples collected in MWCNT facilities. TEM images of
filters collected from personal breathing zone sampling showing: A, more dispersed MWCNT particles; B-C,
agglomerated structures from potentially exposed groups, and D, a media blank (stored in a clean room).
doi:10.1371/journal.pone.0150628.g001
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Differentially expressed ncRNAs and mRNAs in workers exposed to
MWCNT
To profile differentially expressed non-coding and coding RNAs in MWCNT exposed workers,
we performed analysis of miRNA, lncRNA and mRNA expression in the blood samples
between MWCNT exposed and control groups. We found that a total of 977 lncRNAs were dif-
ferentially expressed between MWCNT exposed and the non-exposed workforce groups based
on statistical significance that passed our cutoff filtering (fold change ±1.5, P<0.05). Among
them, 529 lncRNAs were upregulated and 448 lncRNAs were downregulated (S4 Table). Fur-
ther, the statistical analysis of global shifts in mRNA expression revealed a total of 785 genes
Fig 2. An overall schema summarizing the integrated bioinformatics analysis of differentially
expressed ncRNAs andmRNAs to determine their potential relationships and interactions in MWCNT
exposed and non-exposed workers.
doi:10.1371/journal.pone.0150628.g002
Table 1. Elemental carbon (EC) concentrations found for personal breathing zone (PBZs) samples fromworkers performing different tasks.
Process EC inhalable conc., μg/m3 EC respirable conc., μg/m3 %respirable fraction
Harvesting 29.6 6.11 20.65
Mechanical grinding 2.05 2.03 99.03
Packaging 25.3 2.65 10.48
Laboratory handling 0.71 0.54 76.06
Mean ± Std. Error 14.42 ± 3.8 2.83 ± 0.6 -
doi:10.1371/journal.pone.0150628.t001
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(fold change ±1.5, P<0.05) from MWCNT exposed group to show differential expression
compared with samples from non-exposed group (S5 Table). Among these differentially
expressed genes, 292 genes were up-regulated and 493 genes were down-regulated. In addition,
out of a total of 11 differentially expressed miRNAs, 7 were found to be upregulated and 4 miR-
NAs to be downregulated in MWCNT exposed group. The comparison of miRNA and mRNA
expression changes clearly indicate synergistic associations between ncRNAs and mRNAs.
Most importantly, the changes in the expression profiles of ncRNAs and mRNAs were more
prominent in three workers (sample IDs TB1, TB2, TB14), who are potentially exposed to high
levels of MWCNTs (lung burden> 9 μg EC per day; Table 2). A total of 29 miRNAs (with
29"), 2404 lncRNAs (with 1571" & 833#) and 2655 mRNAs (with 1084" & 1571#) were differ-
entially expressed between high MWCNT exposure and non-exposed group (S1 File).Overall,
the mRNA/ncRNA expression changes in MWCNT-exposed workers were related to different
occupations associated within a particular unit/technological process (Tables 1 and 2), rather
than the number of years being employed in the manufacturing facility (~ 1–2 years with lung
burden’s> 9μg EC per day for foreman/technical operators versus ~ 0.5–2 years for scientists/
engineers with lung burden’s< 5μg EC per day).
Association of Dysregulated mRNAs and miRNAs with Known Disease
and Other Outcomes in Rodents
A detailed analysis of dysregulated miRNAs and mRNAs in the blood was performed using IPA
to identify mRNAs and miRNAs associated with various pulmonary and systemic outcomes in
rodents. A list of all differentially expressed mRNAs and miRNAs for each outcome in the over-
all and high MWCNT exposure groups is provided in Table 3. The dysregulated mRNAs and
miRNAs upon exposure to MWCNTs were mostly associated with pulmonary inflammation
and fibrosis, in agreement with many previous in vivo studies reporting inflammatory and
Table 2. Calculated inhalable (I) and respirable (R) elemental carbon (EC) concentrations of workforce and their approximate lung burdens esti-
mated using MPPD (v.2.1) modelling software.
Group Occupation
(sample ID)
Gender (I) TWA 8hr. EC
conc., μg/m3
(R) TWA 8hr. EC
conc., μg/m3
%
respirable
Lung burden
per year (μg)
Lung burden
per day (μg)
Lung burden per
day, mouse (ng)
Exposed TB1 M 17.14 2.78 16.19 3949.92 15.8 7.74
TB2 M 10.37 1.75 16.86 2389.25 9.56 4.69
TB3 M 3.51 0.66 18.6 808.13 3.23 1.59
TB4 M 3.51 0.66 18.6 808.13 3.23 1.59
TB5 M 4.37 1.27 29.09 1005.84 4.02 1.97
TB14 M 17.14 2.78 16.19 3949.92 15.8 7.75
VB1 M 4.37 1.27 29.09 1005.84 4.02 1.97
VB3 M 4.37 1.27 29.09 1005.84 4.02 1.97
Non-
Exposed
TB6 M - - - - - -
TB7 M - - - - - -
TB9 M - - - - - -
TB10 M - - - - - -
TB12 M - - - - - -
VB2 M - - - - - -
VB4 M - - - - - -
The 8hr time-weighted average (TWA) EC concentrations for each occupation in the exposed group were calculated based on inhalable/respirable EC
concentrations of PBZ samples (see Table 1) as well as time spent by the personnel in that particular unit/technological process during a working day.
doi:10.1371/journal.pone.0150628.t002
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fibrotic responses in rodents upon exposure to MWCNTs [14, 48–53]. Eleven mRNAs and
three miRNAs in the overall MWCNT group, and sixty-two mRNAs and four miRNAs in the
high dose group were associated with ‘inflammatory of the lung’ and/or ‘pulmonary fibrosis’.
Several significantly changed mRNAs were also associated with systemic, cardiovascular and
carcinogenic outcomes in the blood of workers exposed to MWCNTs. In the overall MWCNT
exposure group, four mRNAs were associated with ‘vasodilation of arteries’ and seven mRNAs
with ‘atherosclerotic lesions’. Similarly for the high dose group, a total of seventeen and eighteen
mRNAs were associated with ‘atherosclerotic lesions’ and ‘vasodilation of arteries’. While in the
overall exposure group significant mRNAs and miRNAs associated with carcinogenic and other
outcomes considered were either absent or scarce, in the high dose MWCNT exposure group
eight mRNAs—IL6, LTA, TREM2, HGF, VEGFA, CD44, STAT1, BRAF—were associated with
‘granuloma/formation of granuloma’; two mRNAs—OLR1, LGALS3 –were associated with ‘sys-
temic inflammation’; seven mRNAs: TP63, TNK1, TP73, BRAF, XPA, HTAT1P2, NUDT1, and
two mRNAs: EGFR, TNRC6B were associated with ‘pulmonary adenoma’ and ‘broncho-alveo-
lar lung cancer’, respectively; nine mRNAs—PTGS2, PTN, Integrin, Jnk, S100A10, Cdk, FHIT,
Table 3. mRNAs andmiRNAs in the blood of MWCNT exposed workers associated with various pulmonary and systemic outcomes.
MWCNT overall exposure group MWCNT high exposure group
Lung Inflammation and/or
Fibrosis
mRNAs: "EDNRA, "ACKR1, "TRPV4, "LTA,
"CSF2, #P2RY12, #CXCL3, #CCL3L3, #FCGRT,
#TUBB, #RORC
mRNAs: "EDNRA, "PTGIR, "PTGS2, "IL6, "SPHK1, "FGFR1,
"RETNLB, "PLG, "CSF2, "VTN, "CXCL12, "EGFR, "PPARD,
"TNFRSF25, "CHRNG, "ACKR1, "FCGR2B, "CCR5, "TNSF4,
"HRH1, "ST3GAL3, "HMGCR, "IMPDH1, "CDH13, "IKBKE,
"LDLR, "BSG, "CALCA, "MARK2, "RORA, "LTA, "TFPI, "LIPA,
"VEGFA, "TRPV4, "GATA3, "MAPK3, "POMC, "CD276, #CD44,
#STAT1, #GSS, #HLA-DRA, #IL11RA, #RLN2/3, #CD3D, #CD46,
#TSLP, #FGFR3, #LGALS3, #LIF, "TLN1, #CHRNE, #SERPINB1,
#ANXA1, #ADORA1, #IMPDH2, #PRDX, #E2F2, #CASP1, #CYLD,
#NRTN, #C3AR1
miRNAs: "hsa-miR-30a, "hsa-miR-140-3p, #hsa-
miR-92a
miRNAs: "hsa-miR-140-3p, "hsa-miR-21-5p, "hsa-miR-30a-3p,
"hsa-miR-20a-5p, "hsa-miR-27b-3p
Granuloma mRNAs: "LTA mRNAs: "IL6, "LTA, "TREM2, "HGF, "VEGFA, #CD44, #STAT1,
#BRAF
Immunosuppression — mRNAs: "TNFSF4, #Pka
Bronchoalveloar
adenoma
mRNAs: #XPA mRNAs: "TP63,"TNK1, #TP73, #BRAF, #XPA, #HTAT1P2,
#NUDT1
Bronchoalveolar
adenoarcinoma
mRNAs: "TTR mRNAs: "EGFR, "TNRC6B
Formation of Lung
tumors
mRNAs: "Integrin mRNAs: "PTGS2, "PTN, "Integrin, "Jnk, #S100A10, #Cdk, #FHIT,
#ATP Synthase, #RARB
Lung hyperplasisa — —
Goblet cell metaplasia — mRNAs: "HRH1, #ADORA1, #LGALS3
Goblet cell hyperplasia — mRNAs: "IKBKE, "RORA, "GATA3, "CDH13, #TSLP
Systemic Inflammation — mRNAs: "OLR1, #LGALS3
Atherosclerotic lesions mRNAs: "LTA, "VCAM1, "GSTT1, "CSF2,
"BMP7, #Mmp, #CCL3L3
mRNAs: "GSTT1, "LTA, "GPX8, "FUT4, "CCR5, "PLG, "MMP19,
"BMP7, "VEGFA, "CSF2, "LDLR, "TNFSF4, #FUT7, #CXCR1,
#CD44, #CCL3L3, #FABP4, #HMOX2, #CD3, #GRK4, #MIF, #LDL
Vasodilation of Arteries mRNAs: "NOX1, #GUCY1A3, #PDGFB, #RLN2 mRNAs: "VEGFA, "MFAP5, "NOX1, "PIK3R1/R3, "PLG, "LDLR,
"CALCA, "ERK, "PLCD3, #HMOX2, #GUCY1A3, #PDGFB, #SOD1,
#RLN2/3, #PLCL2, #PTPN1, #CELA1
Significantly up- or down-regulated (FC >± 1.5, p<0.05) mRNAs/miRNAs of the overall and high MWCNT exposure groups versus non-exposed workers
associated with each outcome were derived using IPA. miRNAs/mRNAs that are known to increase the disease/other outcomes considered are
highlighted in bold.
doi:10.1371/journal.pone.0150628.t003
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ATP Synthase, RARB—were associated with ‘formation of lung tumor’; three mRNAs—HRH1,
ADORA1, LGALS3 –were associated with ‘goblet cell metaplasia’; and five mRNAs—IKBKE,
RORA, GATA3, CDH13, TSLP—were with ‘goblet cell hyperplasia’. Importantly, many of these
mRNAs had expression direction (up/down regulation) consistent with their known roles lead-
ing to increase in pulmonary and other disease outcomes (Table 3, highlighted in bold). For
example, out of a total of sixty-six mRNAs and miRNAs, twenty-three mRNAs and a single
miRNA (miR-21-5p) are known to increase pulmonary inflammation and/or fibrosis from IPA
knowledge base and were in fact found to be significantly up-regulated in the blood in the high
exposure group. Taken together, these results clearly indicate that mRNAs and miRNAs in the
workers of high exposure group, rather than the overall MWCNT exposed group, are more rem-
iniscent of biological responses upon exposure to engineered nanomaterials. It is well docu-
mented that exposures to engineered nanomaterials, in particular MWCNT, results in
pulmonary inflammation, fibrosis, tumor promotion and cancer progression. Thus, the differ-
entially expressed mRNAs, lncRNAs and miRNAs of only the high exposure group will be sub-
jected to a detailed bioinformatics analysis, as summarized in Fig 2.
Identification and Analysis of lncRNA-mRNA interactions and miRNA-
mRNA target pairs in workers exposed to MWCNT
As ncRNAs are known to participate in transcriptional, epigenetic, and/or post-transcriptional
regulation of gene expression, we predicted and constructed the expression profiles of the tar-
get mRNAs using differentially expressed miRNAs and lncRNAs. Detailed analysis of dysregu-
lated lncRNAs and their 850 nearby coding genes identified a total of 133 differentially
expressed lncRNAs with differentially expressed nearby coding genes (distance<300 kb) in
MWCNT-exposed workers (S1 & S4 Files). Out of these 133 pairs of differentially expressed
lncRNAs and nearby coding genes, 68 pairs were found to be consistent with the direction of
lncRNA expression changes and their sense/antisense relationship (S4 File). The expected
expression of some nearby coding genes of dysregulated lncRNAs was inconsistent with the
mRNA expression changes (S4 File). Further, the analysis of genes targeted by miRNAs, per-
formed using target prediction algorithms, revealed a total of 5442 mRNAs to be targeted by a
total of 19 miRNAs differentially expressed in the high MWCNT exposure group. Following
this, we integrated the predicted potential miRNA based mRNA targets with the differentially
expressed mRNAs profiles in each case (fold change1.5, P<0.05). A total of 115 matched
miRNA-mRNA pairs for 5 differentially expressed miRNAs and 106 differentially expressed
mRNAs were observed for the MWCNT exposed group; and a total of 1232 matched miRNA-
mRNA pairs for 18 differentially expressed miRNAs and 670 differentially expressed mRNAs
for the high dose MWCNT exposed group. The list of top 5 up- and down-regulated genes in
each case along with their known disease associations from IPA knowledge base is provided in
S6 Table. Compared to the overall MWCNT exposed group, the top ranked dysregulated genes
of the highdose group had a significant overlap with known pathological outcomes (e.g., ade-
nocarcinoma, adenoma, fibrosis and tumorigenesis) in rodents upon pulmonary exposure to
MWCNTs [2, 14, 48, 49, 53–56].
IPA Core Analysis of Differentially Expressed mRNAs, miRNAs and
miRNA-mRNA target pairs in the whole blood of workers exposed to
MWCNTs
Table 4 presents the associated categories of diseases and disorders, molecular and cellular
functions as well as physiological system development and functions in the blood of workers
exposed to MWCNT.
Markers of CNT Exposure in Humans
PLOS ONE | DOI:10.1371/journal.pone.0150628 March 1, 2016 12 / 32
Functional Analysis. IPA core analysis based on changes in both mRNA, miRNA and
their mRNA target expression profiles reflect similar outcomes upon exposure to MWCNT.
The diseases and disorders “Cancer”, “Gastrointestinal Disease”, and “Organismal Injury and
Abnormalities” were commonly predicted to be among the top 5 diseases perturbed by differ-
entially expressed mRNAs, miRNAs and miRNA-mRNA target pairs (Table 4). Additionally,
the functional analysis also indicated significant association of genes and miRNAs with cancer
that functioned primarily in cell death and survival and cellular growth and proliferation, upon
exposure to MWCNTs in humans. In addition to their similarities in the disease/disorder and
molecular/cellular functions categories, the dysregulation of both mRNA and miRNA expres-
sion profiles also indicated similarities within each subcategory. For example, in the case of the
top-ranked disease/disorder category “Cancer”, the subcategories lymphoid cancer, hemato-
logic cancer, gastrointestinal tract cancer, digestive system cancer, colorectal cancer and non-
small cell lung cancer (NSCLC) were common. Most importantly, the predicted involvement
of disease/disorder category, NSCLC is in line with previous studies, which reported significant
DE of several genes markers of NSCLC and lung carcinogenesis upon exposure to MWCNT in
rodents. Additionally, IPA analysis also identified “Respiratory Disease” as common to both
changes in mRNA and miRNA expression and one of the top 5 most significant disease and
disorders based on miRNA analysis (Table 4). Further analysis of “Respiratory Disease” cate-
gory indicated similar subcategorical disease outcomes related to NSCLC, and lung carcinoma.
This analysis points out a synergistic association between both miRNAs and mRNAs in
response to MWCNT exposures in humans. Moreover, changes in miRNA expression profiles
Table 4. Functional analysis of differentially expressed mRNAs, miRNAs andmiRNA-mRNA target pairs in the whole blood of workers exposed to
MWCNTs.
mRNA miRNAs miRNA-mRNA targets
Top Five Diseases and Disorders (# of genes / miRNA)
1. Cancer (1932) 1. Cancer (19) 1. Neurological Disease (132)
2. Organismal Injury and Abnormalities (1965) 2. Gastrointestinal Disease (17) 2. Psycological Disorders (63)
3. Infectious Diseases (296) 3. Organismal Injury and Abnormalities (19) 3. Skeletal & Muscular Disorders (79)
4. Gastrointestinal Disease (1318) 4. Respiratory Disease (14) 4. Hereditary Disorder (85)
5. Hematological Disease (390) 5. Reproductive System Disease (12) 5. Tumor Morphology (7)
Top Five Cellular and Molecular Functions (# of genes / miRNA)
1. Cell Death and Survival (636) 1. Cellular Movement (10) 1. RNA Post-transcriptional Modification (27)
2. Protein Synthesis (230) 2. Cell Development (13) 2. Cellular Development (60)
3. Gene Expression (413) 3. Cellular Growth and Proliferation (13) 3. Cellular Growth and Proliferation (57)
4. Cellular Growth and Proliferation (644) 4. Cell Death and Survival (8) 4. Cell to Cell Signaling and Interaction (45)
5. RNA Post-transcriptional Modification (73) 5. Cell Morphology (4) 5. Nucleic Acid Metabolism (27)
Top Five Physiological System Development and Functions (# of genes / miRNA)
1. Organismal Survival (442) 1. Organismal Development (6) 1. Organismal Survival (138)
2. Organismal Development (404) 2. Digestive System Development and
Function (2)
2. Tissue Development (53)
3. Tissue Morphology (445) 3. Hepatic System Development and
Function (2)
3. Auditory and Vestibular System Development and
Function (8)
4. Hematological System Development and
Function (317)
4. Organ Development (3) 4. Hematological System Development and Function
(52)
5. Immune Cell Trafficking (161) 5. Hematopoiesis (3) 5. Immune Cell Trafficking (16)
Significantly up- or down-regulated (FC >± 1.5, p<0.05) mRNAs/miRNAs of the high MWCNT exposure group versus non-exposed workers associated
with ‘disease and disorder’, ‘cellular and molecular functions’, and ‘physiological system development and function’ were determined using IPA.
doi:10.1371/journal.pone.0150628.t004
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also identified (naso-)pharyngeal carcinoma, squamous cell cancer, respiratory system tumor,
idiopathic pulmonary fibrosis, and lung cancer as the most significantly perturbed “Respiratory
disease” outcomes upon exposure to MWCNT in humans. Overall, the IPA functional analysis
of dysregulated mRNAs, miRNAs and its gene targets, clearly suggests the potential of
MWCNT in triggering carcinogenic and other pulmonary disease outcomes in humans, similar
to those seen previously in rodent models [2, 14, 48, 49, 53–56].
Gene Signaling Network Analysis. The IPA top-ranked gene signaling networks (GSNs)
were evaluated to identify potential networks and mechanisms perturbed based on changes in
the expression profiles of mRNAs and miRNA-mRNA target pairs in the whole blood upon
exposure to MWCNTs. The top 10 gene networks predicted using IPA, along with significance
scores, and number of focus molecules are listed in Table 5. The top-ranked signaling network
based on miRNA-mRNA targets was “Cellular Growth and Proliferation, Gene Expression,
Cell Cycle” (score: 39) and on mRNAs was “Cell Cycle, Cell-To-Cell Signaling and Interaction,
Connective Tissue Development and Function (score: 33)” (Table 5). Despite differences in
their associated disease and functions, top predicted GSNs of mRNAs and miRNA-mRNA tar-
gets upon MWCNT exposure in the whole blood predicted the involvement of oncogene
Cyclin D1 (CCND1) as the hub gene. CCND1 encodes for an important cell cycle regulatory
Table 5. Gene Signaling networks of differentially expressed mRNAs andmiRNA-mRNA target pairs
in the whole blood of workers exposed to MWCNTs.
Rank mRNA miRNA-mRNA targets
Top Ten Predicted Associated / Related Network Functions (Prediction Score / # of Focus
Molecules)
1 Cell Cycle, Cell-To-Cell Signaling and
Interaction, Connective Tissue Development
and Function (33/35)
Cellular Growth and Proliferation, Gene
Expression, Cell Cycle (39/30)
2 Cell-To-Cell Signaling and Interaction,
Carbohydrate Metabolism, Developmental
Disorder (29/33)
RNA Post-Transcriptional Modification, Cell
Death and Survival, Cellular Compromise (33/
27)
3 Connective Tissue Development and Function,
Hematological System Development and
Function, Hematopoiesis (29/33)
Cell Death and Survival, Connective Tissue
Disorders, Dermatological Diseases and
Conditions (29/25)
4 Developmental Disorder, Hematological
Disease, Hereditary Disorder (29/33)
Cellular Function and Maintenance, Cell
Morphology, Infectious Diseases (29/25)
5 Cell-To-Cell Signaling and Interaction, Cellular
Movement, Hematological System Development
and Function (29/33)
Cell-To-Cell Signaling and Interaction, Drug
Metabolism, Small Molecule Biochemistry (27/
24)
6 Cell Cycle, DNA Replication, Recombination,
and Repair, Cancer (27/32)
Cell-To-Cell Signaling and Interaction, Cell
Morphology, Reproductive System
Development and Function (26/23)
7 Antimicrobial Response, Inflammatory
Response, Cellular Function and Maintenance
(27/32)
Cardiovascular System Development and
Function, Cell-To-Cell Signaling and Interaction,
Renal and Urological System Development and
Function (26/23)
8 Skeletal and Muscular System Development
and Function, Connective Tissue Development
and Function, Tissue Development (27/32)
Cell Cycle, Inflammatory Disease, Ophthalmic
Disease (26/23)
9 Gene Expression, Connective Tissue
Development and Function, Organismal
Development (27/32)
Cell Cycle, Cellular Development,
Hematological System Development and
Function (22/21)
10 Small Molecule Biochemistry, RNA Post-
Transcriptional Modification, Drug Metabolism
(27/32)
Cancer, Organismal Injury and Abnormalities,
Embryonic Development (19/19)
doi:10.1371/journal.pone.0150628.t005
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protein (Fig 3). A total of 11 genes (CCND1, EIF5A2, ARMCX1, TRAPPC2, DDIAS,
KIAA0101, DEK, PRDX6, PPARGC1B, SUGP2, GPALPP1), out of the 35 focus genes were
predicted to be common to the top-ranked GSNs—network 1 –based on both mRNAs and
miRNA-mRNA target pairs (Fig 3). The biofunctions associated with genes downstream of
CCND1 after MWCNT exposure were those with functional roles in arrest in G1 phase, cell
cycle progression, proliferation, G1/S phase transition and size/morphology of cells and
included cyclins (CCND1,CCND3), cyclin-dependent kinase 4 (CDK4), DNA damage-
induced apoptosis suppressor (DDIAS), DEK proto-oncogene (DEK), peroxisome prolifera-
tor-activated receptor gamma (PPARGC1B) and others (Fig 3A). Similarly for miRNA-mRNA
based target genes (Fig 3B), biofunctions associated with the top GSN network were centered
on expression/transcription of RNA, apoptosis, proliferation and differentiation of cells, G1
phase, G1/S phase transition, arrest in G1 phase, delay in G1/S phase, cell cycle progression,
cell division, oxidative stress response and included CCND1, cell division cycle genes
(CDC27), DDIAS, DEAD (Asp-Glu-Ala-Asp) box helicase 5 (DDX5), hypermethylated in can-
cer 1 (HIC1), lysin specific demethylase A (KDM5A), proliferation associated 2G4 (PA2G4),
DEK Proto-oncogene (DEK), peroxiredoxin 6 (PRDX6) and several others. Most importantly,
CCND1, the hub gene common to the two top most significant GSNs, is known to play major
role in cell cycle: G1/S checkpoint regulation, p53 signaling, aryl hydrocarbon receptor signal-
ing, molecular mechanisms of cancer, (non-)small cell lung cancer signaling and others (Fig 3).
Interestingly, the up regulation of MAML1 was implicated in regulation of epithelial-mesen-
chymal transition pathway and Notch signaling. Many genes common to both GSNs, CCND1,
DDIAS, KIA0101, EIF5A2, PPARGC1B, PRDX6, DEK, were mostly implicated in Cell Cycle,
Cellular Development/Movement/Growth and Proliferation, Inflammatory Response, Immune
Cell Trafficking and Free radical Scavenging. The top 10 most significant GSNs generated
Fig 3. Highest scoring gene molecular networks of mRNAs andmiRNA-mRNA target pairs in MWCNT high exposure group.Gene signaling network
analysis by IPA of differentially expressed (A) mRNAs and (B) miRNA-mRNA target pairs in high MWCNT exposure group. The datasets either containing all
differentially expressed genes or genes having consistent expression direction based on differentially expressed miRNAs were uploaded into IPA then
analyzed with the cutoff criteria of 1.5 fold change and a p-value < 0.05. Only the network is presented for each group. Intensity of the red (upregulated) or
green (down regulated) color of the nodes in the graph indicates level of gene expression.
doi:10.1371/journal.pone.0150628.g003
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based on mRNA and miRNA-mRNA target expression profiles in the blood of workers
exposed to MWCNTs, along with significance scores, and respective hub genes are listed in
Supplemental material, S2 File.
Pathway enrichment analysis of mRNAs and miRNA-mRNA targets in
the whole blood samples of workers exposed to MWCNTs
KEGG pathways enriched by dysregulated mRNAs. Signaling pathways analysis of dif-
ferentially up and down regulated genes, using DAVID [41, 57], predicted the involvement of
95 and 80 pathways (p<0.05), respectively, in the blood of MWCNT high exposure group. A
total of 56 pathways, related to cancer (e.g., pathways in cancer, small- and non-small cell lung
cancer), cellular processes (e.g., apoptosis, focal adhesion, regulation of actin cytoskeleton,
endocytosis, axon guidance, cell cycle, gap- and tight-junction signaling), stress and injury
(e.g., cytokine-cytokine- and ECM-receptor interactions, cell adhesion molecules, MAPK,
PPAR, Jak-STAT, mTOR, Wnt, Calcium signaling), immune system (e.g., Hematopoietic cell
lineage, Natural killer cell mediated cytotoxicity, RIG-I-like receptor, Toll-like receptor, che-
mokine) and circulatory system/cardiovascular disease (e.g, dilated cardiomyopathy, vascular
smooth muscle and cardiac muscle contraction), were commonly enriched by both up and
down regulated mRNAs (Fig 4A, S3 File). Many of these signaling pathways, including apopto-
sis, cell cycle regulation and mitogen activated protein kinase (MAPK) signaling and disease
pathways related to cancer/systemic repsonses, were previously reported to be activated upon
exposure to CNTs [58–65]. In addition to these commonly identified signaling mechanisms,
pathways related to nervous system (e.g., long-term potentiation and depression), neurodegen-
erative diseases (e.g., Huntington’s, Parkinson’s, Alzheimer’s) and processing genetic informa-
tion including those involved in transcription/translation/degradation (e.g., ribosome,
proteasome, RNA degradation, ubiquitin mediated proteolysis) and replication/repair (e.g.,
Nucleotide excision repair, recombination), were found to be uniquely enriched by down-
Fig 4. KEGG pathway enrichment analysis of dysregulated genes andmiRNA-mRNA target pairs in the MWCNT-exposed workers. Venn diagrams
showing common and unique enriched pathways of (A) up- and down-regulated mRNAs KEGG pathways, and (D) down-regulated mRNAs and miRNA-
mRNAs targets identified using micro-TDS and TargetScan algorithms of DIANA-miRPath.
doi:10.1371/journal.pone.0150628.g004
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regulated genes upon MWCNT exposure. The pathways related to signal transduction path-
ways (e.g, ErbB, VEGF, TGFβ), immune system (e.g., Fc gamma R-mediated phagocytosis,
Leukocyte transendothelial migration, complement and coagulation cascades, T- and B-cell,
NOD-like receptor signaling) and endocrine system/metabolic diseases (e.g., Adipocytokine
signaling, type I and type-II diabetes), were uniquely represented by up-regulated genes.
Importantly, the dysregulation of genes that participate in signaling pathways that are common
to both up/down regulated genes clearly highlights and support various adverse outcomes
found previously in rodents and further suggests the potential of MWCNTs to trigger similar
responses in humans.
KEGG pathways enriched by dysregulated miRNA-mRNA target pairs. To identify the
biological pathways enriched by the mRNA targets of the miRNAs upregulated in workers
exposed to MWCNTs, we performed an in silico based analysis of the putative interactions
between the mRNAs targets and the most common KEGG pathways using DIANA-miRPath
[44]. With the use of a threshold P value of 0.001, a total of 40 significantly enriched pathways
were commonly enriched based on both TargetScan and micro-TDS mRNA target prediction
algorithms (Fig 4b, S3 File). Many of these pathways were previously described upon exposure
to CNTs, including MAPK, P53, PI3-Akt, transforming growth factor-beta (TGFβ), and Wnt
signaling pathways, as well as regulation of cell cycle, apoptosis, focal adhesion, and pathways/
transcription misregulation in cancer [47, 58–61, 66]. Further comparison of miRNA-mRNA
enriched signaling pathways with those enriched by down-regulated mRNAs, identified over-
lapping pathways related to Apoptosis (e.g., apoptosis, JAK/Stat, Toll-like receptor signaling),
Cellular growth/proliferation/development (e.g., Jak/STAT, Gap junction, mTOR), and disease
specific pathways (e.g., P53, Pathways in cancer, NSCLC, SCLC, Dilated cardiomyopathy).
Interestingly, a significant number of pathways were also found to be significantly enriched in
organismal systems including endocrine (e.g., GnRH-, Insulin signaling) and nervous (e.g.,
neurotrophin signaling, long-term potentiation) systems. In fact, filtering for miRNA-mRNA
targets with those having consistent down-regulation in the mRNA expression profiles, indi-
cated enrichment of overlapping pathways mostly related to cancer (e.g., pathways in cancer,
NSCLC) and cardiovascular/circulatory system effects (e.g., cardiac muscle contraction, vascu-
lar smooth muscle contraction) as well as cell cycle/movement (Table 6).
Overall the pathway analysis of mRNAs and miRNA-mRNA targets in the blood of workers
exposed to MWCNTs suggests the potential of MWCNTs in triggering carcinogenic and car-
diovascular outcomes as well as highlights the synergistic role of mRNAs and miRNAs in driv-
ing such responses.
Regulatory Network Generation and Analysis of ncRNA-mRNA co-
expression and interactions in the whole blood of workers exposed to
MWCNTs
To identify and understand the synergistic interactions and overall patterns in the dysregula-
tion of ncRNAs and mRNAs, a comprehensive analysis of their potential relationships was per-
formed to generate a regulatory network by integrating the co-expression changes, interactions
and positional details of lncRNAs, mRNAs and miRNAs. As a first step, all experimentally vali-
dated mRNA target pairs of significantly differentially expressed miRNAs (p<0.05, fold-
change>±1.5) were selected and further filtered for their consistent differential expression in
mRNA profiles. Following this, the direct and indirect interactions as well as regulatory rela-
tionships between these biological molecules were identified using IPA and was represented as
a network. Some miRNAs, such as miR-20a-5p, a member of miR-17-92 cluster, and miR-
146a-5p, were located in the central positions with multiple target mRNAs. Most of the
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mRNAs (e.g., CCND1, SMAD5) also showed consistent dysregulation patterns based on their
up and/or downstream targets (Fig 5). The information corresponding to the positional rela-
tionships of mRNA/miRNA and lncRNAs were further incorporated into the regulatory net-
work, to identify the role of lncRNAs in further regulating this network. Often these mRNA-
lncRNA pairs had sense/antisense relationships, indicating their consistent expression (S4
File). The overall regulatory network indicated that the signaling mechanism triggered by
mRNAs was prone to be downregulated in MWCNT-exposed workers.
None of the dysregulated miRNAs identified were significantly downregulated in
MWCNT-exposed workers. However, the functional analysis of all dysregulated mRNAs indi-
cated activation of mechanisms and pathways involving up-regulated genes (Figs 3A and 4A;
Table 6. KEGG signaling pathway enrichment of miRNA-mRNA targets in the whole blood of workers exposed to MWCNTs.
Rank KEGG pathway p-value #genes #miRNAs
1 Prion diseases 1.71E-46 2 2
2 Synthesis and degradation of ketone bodies 1.87E-08 3 3
3 Butanoate metabolism 5.25E-07 4 3
4 Valine, leucine and isoleucine degradation 2.88E-06 4 2
5 Pathways in cancer 6.62E-06 8 6
6 Thyroid cancer 4.52E-05 3 4
7 Non-small cell lung cancer 4.77E-05 3 3
8 Folate biosynthesis 0.00027464 1 1
9 Fatty acid metabolism 0.00030932 2 2
10 Bladder cancer 0.0007482 3 3
11 Prostate cancer 0.00215104 4 3
12 Colorectal cancer 0.002305 3 3
13 Insulin signaling pathway 0.00251161 5 3
14 Endometrial cancer 0.00267391 3 3
15 Melanoma 0.00312374 3 3
16 Cell cycle 0.00314939 5 3
17 Terpenoid backbone biosynthesis 0.00321421 2 2
18 Chronic myeloid leukemia 0.00414792 3 4
19 Focal adhesion 0.00546325 6 6
20 Small cell lung cancer 0.00576343 3 2
21 Herpes simplex infection 0.00589366 6 4
22 Long-term potentiation 0.00806107 3 2
23 Oocyte meiosis 0.00987416 4 2
25 Pancreatic cancer 0.02183958 3 3
24 Progesterone-mediated oocyte maturation 0.02183958 3 2
26 Fatty acid elongation 0.02315225 1 1
27 Vascular smooth muscle contraction 0.03280908 3 2
28 Vasopressin-regulated water reabsorption 0.03827082 2 1
31 Cardiac muscle contraction 0.04415137 2 2
29 Vibrio cholerae infection 0.04572276 2 2
30 Non-homologous end-joining 0.0464634 1 1
The KEGG pathway enrichment analysis was performed using DIANA-mirPath [44]. The mRNA targets of significantly up-regulated (FC > 1.5, p<0.05)
miRNAs of the high MWCNT exposure group versus non-exposed workers were predicted using TargetScan algorithm and the resulting mRNA target list
was further filtered for those with significant down-regulation (FC > 1.5, p<0.05) in the mRNA expression profiles obtained from same samples. The
enriched pathways overlapping with those predicted based on all down-regulated mRNAs, using DAVID, are highlighted in bold.
doi:10.1371/journal.pone.0150628.t006
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S3 File), with key roles in several disease outcomes (e.g., cancer, respiratory diseases, fibrosis).
Moreover a number of upregulated mRNAs had consistent co-expression and positional rela-
tionship to lncRNAs (S4 File), suggesting their regulatory roles in MWCNT-induced biological
responses. Thus, down regulated miRNAs identified in high MWCNT exposure group, albeit
with no statistical significance, were considered to generate a regulatory network (as described
above) that accounts for and incorporates signaling mechanisms associated with the up-regu-
lated mRNAs. The hsa-miR-16-5p was located in the central position with most of the target
mRNAs. The lncRNA RP11-533O20.2 has its expression consistent with one of its nearby cod-
ing gene, CCND3. The expression of some downregulated miRNAs including hsa-miR-16-5p,
despite their low statistical significance, were consistent with and also showed coordinated
changes with respect to significantly dysregulated lncRNAs (Fig 5B). Interestingly, the gener-
ated regulatory networks of ncRNAs and mRNAs indicated that biological functions and dis-
eases represented by these molecules were mostly associated with cellular growth/
development/proliferation, cell death/apoptosis and cancer. Overall the regulatory network
analysis suggests that the dysregulation of biological pathways and mechanisms in MWCNT-
exposed workers is mediated by coordinated changes at the genetic and epigenetic stages of the
transcriptome.
Validation of aberrantly expressed genes corresponding to mRNAs and
miRNA-mRNA target pairs by qRT-PCR
The differences in gene expression found by microarray analyses were validated by using quan-
titative real time RT-PCR (qRT-PCR). We chose a total of six genes (CCND1, CCND3, MUC1,
E2F2, TGFβ1 and SOD1) with ± 1.5 fold dysregulation in the whole blood of MWCNT-
exposed workers. Some of the selected genes (e.g., CCND1, E2F2, CCND3) are known targets
of the miR-16-5p or other dysregulated miRNAs belonging to the oncogenic miR-17-92 family
Fig 5. The regulatory network of ncRNAs andmRNAs in workers exposed to MWCNTs. The regulatory networks of significantly dysregulated lncRNAs
and mRNAs (p-value<0.05, fold-change>±1.5) having positional and/or functional relationship with (A) up-regulated miRNAs (p<0.05, fold-change>1.5) and
(B) down-regulated miRNAs (p>0.05, fold-change>-1.5), generated using IPA. The lncRNAs, represented using red (#) and green (") rectangles and dotted
lines, with consistent co-expression as mRNAs and/or containing miRNA target binding sites from starBase v2.0 were manually added to the network.
doi:10.1371/journal.pone.0150628.g005
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in MWCNT-exposed workers. The expression of CCND3 and MUC1 was up-regulated and
CCND1, E2F2 and SOD1 were down-regulated in RT-qPCR studies, in accordance with their
differential expression in the same subjects exposed to MWCNTs (Table 7). Although some
variation concerning the degree of regulation was observed, the overall data obtained with
microarrays were substantially confirmed by qRT-PCR for almost all genes associated with cell
cycle regulation and fibrotic responses, with the exception of TGFβ1(Table 7). The real-time
PCR result of TGFβ1 showed an opposite trend in its regulation compared to its microarray
expression changes. While TGFβ1 showed a negative regulation based on minimum detection
limit values for two of the three exposed subjects and was not considered for initial analysis,
several of its up-/down-stream regulators showed expression consistent with the up-regulation
of TGFβ1. Surprisingly, the RT-qPCR result of TGFβ1 is in line with this. Of the five genes that
showed the same trends of up- and down-regulation as the microarray data, four of them were
statistically significant (p<0.05), supporting an overall consistency (Pearson r = 0.79, P<0.05)
between the RT-qPCR results and the microarray data.
Discussion
To date, there has been no report of definitive disease and/or potential biomarkers of early
health effects in humans exposed to CNTs. The whole blood gene expression profiling, as sur-
rogate to tissue, has become a powerful and an informative approach to investigate various dis-
ease states and identity biomarkers. This pilot study has revealed changes in the lncRNA,
miRNA and mRNA expression profiles in the whole blood samples of MWCNT exposed
humans and suggests the potential of MWCNTs in triggering carcinogenic, pulmonary and
cardiovascular outcomes as well as highlights the synergistic role of mRNAs, miRNAs and
lncRNAs in driving such responses. This study is the first to show a total of 977 lncRNAs, 785
mRNAs and 17 miRNAs were differentially expressed (fold change±1.5, P<0.05) between
MWCNT exposed and the non-exposed workforce groups. We found that these changes were
much more prominent in a sub-set of three individuals (Table 2, Sample IDs: TB1, TB2 and
TB14) that were associated with specific roles within an occupational setting (e.g., foreman,
technical operator) where they were exposed to higher EC concentrations than other workers
in the facility (Table 2).The changes in expression profiles revealed a total of 2404 lncRNAs,
2655 mRNAs and 29 miRNAs to be differentially expressed among these occupations com-
pared to non-exposed workforce employed in the same facility. This suggests an occupation
dependent potential exposure to high levels of MWCNTs (Table 1). This is in line with the
Table 7. Real time PCR validation of microarray expression data using select genes in the whole
blood of workers exposed to MWCNTs.
Gene Microarray Data FC (range) RT-qPCR Data (range)
CCND1 -1.8 (-1.4 to -2.3) -2* (-3.3 to -1.2)
CCND3 2.4 (2.8 to 2.0) 1.64* (1.1 to 2.4)
E2F2 -5.1 (-2.9 to -8.6) -1.4 (-2.4 to 1.2)
MUC1 3.4 (4.9 to 1.9) 1.6* (1.1 to 2.2)
SOD1 -6.2 (-3.3 to -7.4) -1.5* (-2.3 to 1.0)
TGFβ1 -1.4 (-1.3 to -1.5) 1.5* (-1.2 to 2.5)
Isolated mRNA was reverse-transcribed and subjected to RT-qPCR reaction with Roche Taqman probes.
Data represent Mean fold change values along with their lower and upper limits of expression changes,
n = 3.
*p < 0.05.
doi:10.1371/journal.pone.0150628.t007
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detailed TEM and EC analysis of PBZ samples collected at the MWCNT manufacturing facili-
ties that determined highest exposure levels in harvesting and packaging areas. While the TEM
analysis clearly indicated the presence of inhalable/respirable fractions of CNTs, EC analysis
suggested potential exposure to CNTs at concentrations higher than the NIOSH recommended
exposure limit (REL) of 1 μg/m3 for an 8 h TWA (Table 2 and S3 Table).
Biological responses associated with CNTs exposure can vary by the type of CNTs (e.g, sin-
gle-, double- and multi-walled; long and short, tangled or straight), pulmonary exposure meth-
ods employed (e.g, inhalation, intra-tracheal instillation, or pharyngeal aspiration), and the
dose of CNTs investigated [14, 49–51, 67, 68]. Despite these variations, the pulmonary toxicity
studies of CNT exposure in rodents conducted to date have reported consistent non-cancerous
adverse pulmonary effects including inflammation, evidence of oxidative stress, epithelial-mes-
enchymal transition and fibrosis [14, 48, 49, 51, 67, 68]. This is also evident in our study where
changes in mRNA and miRNA expression profiles in the whole blood of MWCNT exposed
workers was associated with various pulmonary outcomes (Table 3). The number of dysregu-
lated mRNAs and miRNAs associated with pulmonary inflammation and fibrosis were consid-
erably more compared to other outcomes, in agreement with CNT-induced early events or
responses reported by many previous in vivo studies. Several of these mRNAs, including cyto-
kines (e.g., IL6, CSF2, CXCL2), growth factors (e.g., VEGFA, PDGFA), and miRNAs (e.g., hsa-
mir-21-5p, has-mir-27b-3p) are all known to increase inflammation and/or fibrosis. A recent
study that investigated miRNA/mRNA expression profiles also reported the overexpression of
mir-27b-3p in the blood from mice exposed to MWCNT via Inhalation [54]. In fact, the up-
regulation of mir-27b-3p was exclusive to the fibrosis category, confirmed pathologically in the
lungs [54]. Previous in vivo studies using rodent models clearly revealed a profibrotic potential
of MWCNTs triggered by TGFβ, one of the key profibrotic mediators in the pathogenesis of
pulmonary fibrosis. While, no change related to expression levels of TGFβ was found in
MWCNT exposed workers, a significant enrichment of the TGFβ signaling pathways overrep-
resented by the up-regulated genes and the dysregulation of several mediators either involved
in its signaling (e.g., SP1, SMAD6, MAPK, BMP7) or up-/down-stream (e.g., IL6, PTGS2,
EGFR, MEF2D, PDGFA, FN1) had expression consistent with predicted activation or up-regu-
lation of TGFβ1 in workers exposed to MWCNTs. Moreover, many of these genes have been
linked to the development of fibrosis. Several chronic inflammatory conditions including fibro-
sis is a key marker in asbestos-induced pathological responses. Several in vivo and in vitro stud-
ies suggest that CNTs elicit biological responses similar to those observed for asbestos fibers
[15, 69]. Importantly, exposure to MWCNTs and asbestos fibers revealed similarities in the
expression of various markers of mesothelioma and/or cancer [52, 70]. The expression levels of
some of these exposure markers, in particular TGFβ1 and MUC1, were found to be signifi-
cantly increased in the whole blood samples of MWCNT exposed workers (Table 7). The levels
of these markers observed in our study are in line with a recent pilot cross-sectional study
which reported elevated levels of MUC1 and TGFβ1 in the induced sputum or serum samples
of MWCNT exposed workers [71]. The serum levels of MUC1 or Krebs von den Lungen-6
(KL-6) have been demonstrated to be a useful marker for the diagnosis and monitoring of
patients with various interstitial lung diseases including pulmonary fibrosis[72–74]. Morover, a
positive association between the serum levels of MUC1/ KL-6 and risk of lung cancer was also
reported [75]. This is compatable with a fibrogenic and/or carcinogenic potential of MWCNTs
in humans, similar to that of asbestos fibers [15, 52, 69].
In addition to the early non-cancerous pulmonary effects, some in vitro and in vivo studies
have shown genotoxic or carcinogenic effects upon exposure to MWCNTs. Inhalation expo-
sure to MWCNT has been linked with lung fibrosis that could lead to epithelial to mesenchy-
mal transition and promotion of tumor formation/progression/metastasis. Several cell-
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adhesion molecules (e.g., ITGA2, VCAM1, and COL4A) and extracellular-matrix proteins
(e.g., FN1, VTN) exhibited dysregulation upon exposure to MWCNTs in humans. Especially,
the overexpression of some of these EMT related factors are known to further support tumori-
genic responses. While the increased expression of VCAM1 promotes tumor invasion and
metastasis [76], high levels of VTN and/or FN1 in circulation have been reported to promote
tumor formation and metastasis [77–79]. Similarly, their overexpression in the blood samples
of MWCNT exposed workers is also in complete agreement with rodent studies which reported
the promotion of lung tumor/adenoma/adenocarcinoma formation, progression and meta-
static upon treatment with either SWCNTs or MWCNTs [56, 66, 80, 81]. Further, the func-
tional analysis of IPA pointed out a synergistic role of both miRNAs, and mRNAs in predicting
various disease/disorder outcomes including “Cancer” and “Respitaroty Disease”. Consistent
with previous studies, our results also identified various pulmonary adverse effects (e.g.,
NSCLC, respiratory system tumor, Idiopathic pulmonary fibrosis, and lung carcinoma) as sub-
categories within the Cancer and/or Respiratory Disease categories.
Based on the close relationship and association between inhalation of ambient ultra-fine par-
ticles and increased risk of cardiovascular diseases [82–84], it has been suggested that exposure
to carbon-based nanomaterials including CNTs might have the potential to induce systemic
and immune responses. Some of the top ranked “Physiological System Development and Func-
tions” predicted (e.g., Hematological system, Immune cell trafficking) using IPA functional
analysis in this study also supports this notion. Additionally, the enrichment of several KEGG
signaling pathways related to circulatory/cardiovascular and immune system was also observed
based on dysregulated blood gene expression profiles of workers exposed to MWCNTs. Previ-
ous studies on pulmonary exposure to CNTs have reported various systemic responses in ani-
mals, including an increase in inflammatory mediators in the blood, oxidative stress in distant
organs/tissues (e.g., Aorta, Spleen), and myocardial infarction as well as increased plaque forma-
tion in an atherosclerotic mouse model [62, 64, 85–88]. Interestingly, several genes associated
with “Atherosclerotic lesions” were also found to be dysregulated in MWCNT exposed workers.
The expression of many of these genes (e.g., VCAM1, LTA, PLG, CSF2, VEGFA, and TNFSF4)
was consistent with their role in exacerbating atherosclerotic lesions, further corroborating the
ability of MWCNTs in triggering such systemic responses. Especially, the overexpression of
VCAM1 in the overall exposure group, dominated by workers who spent less time in the facility
or had low exposure to MWCNTs (Table 2), supports the fact that exposure to even low concen-
trations of MWCNTs can have significant systemic and immune responses, despite no or low
pulmonary toxicity [85, 86]. Furthermore, pulmonary exposure to MWCNT was previously
shown to reduce the ability of coronary arterioles to respond to dilators [65]. Similarly in this
study, a significant decrease in the expression of many factors (e.g., SOD1, RLN2/3, HMOX2,
CELA1, GUCY1A3, ADORA1, GNAS, CAMK2D), known to be associated with increased
“vasodilation of arteries” (Table 3) or “cardiac dilation”, was observed in MWCNT exposed
workers. In addition, the KEGG pathway enrichment analysis of down-regulated mRNAs, con-
sistent with matched up-regulation of miRNAs, resulted in the enrichment of the “vascular
smooth muscle- and cardiac muscle contraction”. This suggests that pulmonary exposure to
MWCNTs might have the ability to decrease or inhibit muscle dilation in humans. The mRNA
and miRNA expression changes upon exposure to MWCNTs in humans are well correlated
with their ability to intensify or worsen pre-existing cardiovascular related diseases. A recent
study by Erdely and Coworkers also demonstrated a close cross-talk between the pulmonary
and systemic circulation, suggesting that a systemic response if chronic and persistent can initi-
ate or exacerbate cardiovascular disease and dysfunction [64]. Most importantly the decreased
expression of SOD1 and increased VCAM1 and IL6 levels were also reported by several
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epidemiological studies as potential biomarkers for medical surveillance of workers handling
engineered nanomaterials [89, 90].
Identification and development of nanomaterial exposure-related biomarkers in the blood
would be quite useful for monitoring as well as early diagnosis of various health effects in
humans. Recently, miRNAs have attracted considerable attention as non-invasive biomarkers
of a variety of human diseases (e.g., cancers), due to their remarkable stability and tolerance to
RNase activity as well as extreme physiological conditions [91–94]. miRNAs are a family of
small (~ 19–24 nucleotides long) non-coding functional RNAs that modulate gene expression
of target mRNAs by binding to the 30UTRs. Several studies also point towards their key role in
regulating cellular processes and pathways that are critical for neoplastic transformation and
tumor progression [93, 95–97]. The dysregulation of some miRNAs, referred to as “oncomiRs”,
is associated with carcinogenesis and in promoting certain oncogenic events of cancer [98, 99].
A significant up-regulation of oncomiR mir-21-5p and miR-20a-5p (belonging to oncogenic
miR-17-92 family or cluster) was found in the blood samples of MWCNT exposed workers (S1
File). The elevated expression of these miRNAs were reported in a variety of cancers including
NSCLC and lung cancer [100] and are known to play roles in cell cycle regulation, apoptosis,
cancer invasion and metastasis. Importantly, the different members of miR-17-92 cluster
including miR-20a-5p –located on Chr13q31 –and mostly target genes involved in regulation
and execution of G1/S transition, such as CCND1, E2Fs. The expression of both CCND1 and
E2F2 was in fact found to be significantly down-regulated upon exposure to MWCNTs in this
study (Fig 5A), further validating the increased levels of miR-20a-5p in our study and its regu-
latory role in targeting these genes (Fig 5A). The formation of CCND1-CDK4 complex is criti-
cal for regulating the cell-cycle during G(1)/S transition. Interestingly, the expression levels of
mRNA coding for CDK4, in addition to CCND1, was also significantly decreased in MWCNT
exposed workers. This suggests a cell cycle arrest at G1 phase, as elevated levels of CCND1–
CDK4 complex promotes the transit from G0 to G1 during cell cycle, shortening the G1 cell
cycle phase. This notion is further supported by the functional analysis studies of dysregulated
mRNAs/miRNAs-mRNA target pairs performed in this study. The predicted top-ranked GSNs
indicated CCND1 as the common hub gene exerting various biological functions with related
roles in arrest in G1 phase, cell cycle progression, proliferation, G1/S phase transition and size/
morphology of cells. Consistent with this, exposure to MWCNT bucky paper was shown previ-
ously to reduce the expression of CCND1/CDK4 as well as cell proliferation by triggering cell
cycle arrest in G0/G1 phase and increase apoptosis in human leukemia cell lines through mod-
ulation of AKT and MAPK signaling pathways[59]. Similar results were also obtained on
human normal peripheral blood lymphocytes where MWCNT bucky paper treatment blocked
cell cycle progression by arresting cells at G0/G1 phase[101]. Especially, the enrichment of
KEGG pathways including apoptosis, cell cycle regulation, PI3-Akt and MAPK by both up-/
down-regulated mRNAs in the MWCNT exposed group further correlates MWCNT induced
survival and apoptosis responses described previously (S3 & S4 Files). These findings suggest
that MWCNTs are capable of exerting both cytostatic and cytotoxic effects in the whole blood
of humans exposed to MWCNTs. In contrast to CCND1 & CDK4, a significant upregulation
of another cyclin D member, CCND3 was observed upon MWCNT exposure. It has to be
noted that the overexpression of CCND3 and down-regulation of CCND1 is further supported
by a complex regulatory network involving noncoding miRNAs and lncRNAs (Fig 5). The up-
regulation of CCND3 is further corroborated by the decreased levels of hsa-miR-16-5p in
MWCNT-exposed workers (albeit with a p-value> 0.05). In addition to targeting CCND3,
hsa-miR-16-5p is also known to regulate the expression of various angiogenic (e.g., PTGS2,
VEGF, FGFR) and/or carcinogenic factors (e.g. EGFR, BMP7, MAPKs) with key roles in can-
cer/disease signaling pathways (Fig 5B). Most importantly, the overexpression of CCND3,
Markers of CNT Exposure in Humans
PLOS ONE | DOI:10.1371/journal.pone.0150628 March 1, 2016 23 / 32
probably to substitute for significantly decreased expression of CCND1 & CDK4, can result in
dysregulation of the cell cycle and may further contribute to malignant phenotype of cells upon
exposure to MWCNTs [102]. Some of these aberrantly expressed miRNAs are also located in
chromosomal regions (e.g., chr13) frequently amplified in lung cancers [103]. Several in vitro
studies also reported the potential of MWCNTs to induce inhibition of proliferation, cell cycle
delay, apoptosis, malignant transformation, genotoxicity and abnormal chromosome number
by interfering with mitosis (cell division) in various in vitro and in vivo studies [59, 101, 102,
104–111]. In fact, some of the miRNAs (e.g., "hsa-miR-20a-5p, "hsa-miR-21-5p, "hsa-miR-
23a-5p, #hsa-miR-16-5p) and their mRNA targets aberrantly expressed in exposed workers are
known to play critical roles in cell proliferation, apoptosis, tumor invasiveness and tumorigene-
sis as well as the pathogenesis of cancer including and NSCLC [103, 112–120]. Taken together,
the results presented in this paper may suggest the onset of carcinogenic risk in humans poten-
tially exposed to MWCNTs.
Conclusions
In summary, we have performed a comparative analysis of ncRNA and mRNA expression pro-
files in non-exposed and workers exposed to MWCNT aerosols and provide important insights
into the molecular details, pathways and regulatory networks of MWCNT-induced toxicity in
humans. To the best of our knowledge this study is one of the first to investigate aberrant
changes in mRNA and ncRNA expression profiles in the whole blood of humans exposed to
MWCNTs. Identified changes in ncRNA and mRNAs, pathways and signaling networks
revealed potential health risks and other outcomes associated with occupational exposures to
MWCNTs. Although the aberrant changes in miRNAs, particularly in combination with their
mRNA targets, have a promising potential as relevant blood markers for monitoring MWCNT
exposure in humans, their potential prognostic value still needs further validation. It has to be
noted that there are several limitations to this study including small sample size. A prospective
large-scale study involving periodic collection of blood samples over longer latency periods
and multiple CNT manufacturing locations along with detailed quantification of various cells
in the blood and the role of confounding factors such as age, sex and smoking history, however,
are required to further corroborate our findings. Such studies are underway and will support
the potential applicability of the described blood markers to identify and monitor potential
exposure and health risks associated with occupational exposure to MWCNTs.
Supporting Information
S1 Fig. Classification of CNT structures: matrix particles (A, B) and CNT cluster (C).
(TIF)
S1 File. Differentially regulated ncRNA and mRNA profiles in the high exposure group.
The differentially up and down-regulated mRNA, lncRNA and miRNAs in the whole blood of
workers from the high exposure group.
(XLSX)
S2 File. Top ranked gene signaling networks based on mRNAs and miRNA-mRNA target
pairs using IPA. The top 10 most significant GSNs generated based on mRNA and miRNA-
mRNA target expression profiles in the blood of workers exposed to MWCNTs, along with sig-
nificance scores, and their respective hub genes.
(XLSX)
S3 File. KEGG pathway enrichment analysis of dysregulated mRNAs and miRNA-mRNA
target pairs in the blood of the MWCNT high exposure group. The KEGG pathway
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enrichment analysis of up/downregulated mRNAs and mRNA targets of dysregulated miRNAs
profiles were performed using DAVID[41] and DIANA-mirPath (ref), respectively. The pre-
diction of mRNA target pairs corresponding to the up-regulated miRNAs was performed using
both TargetScan and micro-TDS algorithms, provided by DIANA-miRPath. The KEGG path-
ways overrepresented by the mRNA target pairs of dysregulated miRNAs were cross compared
to pathways enriched by downregulated mRNAs.
(XLSX)
S4 File. The comprehensive list of all significantly dysregulated lncRNAs and their nearby
coding genes (p-value<0.05, fold-change>±1.5) in the MWCNT high exposure group. The
nearby coding genes identified based on their positional relationship to lncRNAs includes bidi-
rectional, exon sense-overlapping, intergenic, intro sense-overlapping, intronic antisense and
natural antisense relationships.
(XLSX)
S5 File. The list of all aberrantly expressed miRNAs (fold-change>±1.5) and their corre-
sponding interactions with dysregulated lncRNAs in the MWCNT high exposure group.
The lncRNA–miRNA interaction dataset was downloaded with medium stringency from star-
Base v2.0 database [31, 32] in September, 2015. This dataset provides the most comprehensive
list of experimentally confirmed and predicted lncRNA–miRNA interactions based on large
scale CLIP-Seq data.
(XLSX)
S1 Table. The physical and chemical properties of MWCNTs as reported by the
manufacturing facilities investigated.
(XLSX)
S2 Table. Total CNT structure counts (CNT/mm2) for personal breathing zone samples,
along with their maximum crosswise length distribution. Counts based on results (struc-
tures/grid openings) for three TEM grids.
(XLSX)
S3 Table. Total and respirable elemental carbon (EC) concentrations of air samples col-
lected in different technological and plant background areas of Nanotech center ltd.
MWCNT facility (Tambov, Russia).
(XLSX)
S4 Table. Whole blood LncRNA expression profiles in humans exposed to MWCNT.Differ-
entially expressed lncRNAs in the blood samples of workers non-exposed and potentially
exposed to MWCNTs. (FC 1.5; P<0.05).
(XLSX)
S5 Table. Whole blood mRNA expression profiles in humans exposed to MWCNT. Differ-
entially expressed mRNAs in the blood samples of workers non-exposed and exposed to
MWCNTs. (FC 1.5; P<0.05).
(XLSX)
S6 Table. Disease association of dysregulated genes corresponding to mRNAs and miRNA-
mRNA target pairs. The top five significantly (P< 0.05) up- and down- regulated genes corre-
sponding to mRNAs and miRNA-mRNA target pairs of the overall and high exposure groups.
(XLSX)
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